tmci: the cashflow

MyFinsight

For the quarter ending 2025-09-30.

Unit: Thousand (K) dollars (except for numbers of shares and EPS)

Cash Flow	2025-09-30	2025-06-30
Net cash provided by (used in) financing activities	695	705
Net increase (decrease) in cash and cash equivalents	-3,664	-3,298
Cash and cash equivalents at beginning of period	11,350	-
Cash and cash equivalents at end of period	7,686	-

Unit: Thousand (K) dollars (except for numbers of shares and EPS)

For the quarter ending 2025-09-30.

Unit: Thousand (K) dollars (except for numbers of shares and EPS)

Cash Flow	2025-09-30	2025-06-30
Net cash provided by (used in) financing activities	695	705
Net increase (decrease) in cash and cash equivalents	-3,664	-3,298
Cash and cash equivalents at beginning of period	11,350	-
Cash and cash equivalents at end of period	7,686	-

Unit: Thousand (K) dollars (except for numbers of shares and EPS)

TREACE MEDICAL CONCEPTS, INC. (TMCI)